Cancer Cell International (Apr 2022)
Eukaryotic translation initiation factor 3 subunit B promotes head and neck cancer via CEBPB translation
Abstract
Highlights EIF3B is a prognostic biomarker for HNSCC risk; EIF3B promotes HNSCC progression in vitro and in vivo; EIF3B promotes CEBPB translation and activates the MAPK pathway; IL6R and CCNG2 are targets of EIF3B-regulated CEBPB translation.
Keywords